Bet1L gene silencing commonly showed more severe effects in ALS rats, indicating that the disease progression was accelerated by Bet1L siRNA injection, and the disease stage shifted from pre-symptomatic to symptomatic. This evidence concerns the gene BET1L and amyotrophic lateral sclerosis.